References
- Kutty S, Sengupta PP, Khandheria BK. Patent formane ovale: the known and the to be known. J Am Coll Cardiol 2012;59(19):1665-71
- NICE 2005. NICE interventional procedure guidance 109. Available from: www.nice.org.uk/nicemedia/live/11140/31253/31253.pdf
- Bridges ND, Hellenbrand W, Latson L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86(6):1902-8
- Jefferson T, Migliore A, Abraha I, Montedori A. Implantable devices for the closure of patent foramen ovale (PFO) in adults: rapid HTA report. Agenas, Agenzia nazionale per i servizi sanitari regionali; Italy: 2013
- Jefferson T. Rapid Health Technology Assessment for Agenas. Italy: 2012
- Higgins JPT, Green S. editors. Cochrane handbook for systematic reviews of interventions version 5.0.2 [updated September 2009]. The Cochrane Collaboration. 2009. Available from: www.cochrane-handbook.org
- Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: www.ohri.ca/programs/clinical_epidemiology/oxford.asp
- Thanopoulos BV, Dardas PD, Karanasios E, Mezilis N. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Catheter Cardiovasc Interv 2006;68(5):741-6
- Schuchlenz HW, Weihs W, Berghold A, et al. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale. Int J Cardiol 2005;101(1):77-82
- Casaubon L, McLaughlin P, Webb G, et al. Recurrent stroke/TIA in cryptogenic stroke patients with patent foramen ovale. Can J Neuro Sci 2007;34(1):74-80
- Carroll JD, Saver JL, Thaler DE, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013;368(12):1092-100
- Harrer JU, Wessels T, Franke A, et al. Stroke recurrence and its prevention in patients with patent foramen ovale. Can J Neuro Sci 2006;33(1):39-47
- Windecker S, Wahl A, Nedeltchev K, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44(4):750-8
- Landzberg MJ, Khairy P. Patent foramen ovale: when is intervention warranted? Can J Cardiol 2013;29(7):890-2
- US FDA. FDA report: Unsafe and ineffective devices approved in the EU that were not approved in the US. 2012. Available from: www.elsevierbi.com/∼/media/Supporting%20Documents/The%20Gray%20Sheet/38/20/FDA_EU_Devices_Report.pdf
- Cohen D. How a fake hip showed up failings in European device regulation. BMJ 2012;345:e7090
- Cohen D, Billingsley M. Europeans are left to their own devices. BMJ (Clinical research ed.). 2011.342:d2748. Available from: www.bmj.com/content/342/bmj.d2748
- Coombes R. Europe’s plan to tighten regulation of devices will not reach US standards. Br Med J 2012.345:e6303. Available from: www.bmj.com/content/345/bmj.e6303.pdf%2Bhtml
- Campillo-Artero C. A full-fledged overhaul is needed for a risk and value-based regulation of medical devices in Europe. Health Policy 2013;113(1-2):38-44
- Migliore A, Ratti M, Cerbo M, Jefferson T. Health technology assessment: managing the introduction and use of medical devices in clinical practice in Italy. Expert Rev Med Devices 2009;6(3):251-7
- Hulstaert F, Neyt M, Vinck I, et al. Pre-market clinical evaluation of innovative high-risk medical devices in Europe. Int J Technol Assess Health Care 2012;28(3):278-84
- AIM, ESIP. ISDB and MiEF position paper. 2012. Available from: www.esip.org/files/AIM-ESIP-ISDB-MiEF%20position%20paper%20on%20reform%20Medical%20device.pdf
- Eikermann M, Gluud C, Perleth M, et al. On behalf of signatories of our open letter to the European Union. Commentary: europe needs a central, transparent, and evidence based regulation process for devices. BMJ 2013;346:f2771
- Eucomed Position Paper, January 2013. Towards a regulation that guarantees patient safety, ensures patient access and keeps innovation in Europe. 2013. Available from: www.medtecheurope.org/uploads/Modules/Publications/20130130_2013_eucomed_detailed_position_on_proposal_mdd_revision.pdf
- Miller FG, Pearson SD. Coverage with evidence development: ethical issues and policy implications. Med Care 2008;46(7):746-51